Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

The Power of Nucleic Acid Mimics (NAMs) in Advanced Genetic Research | LifeTein Peptide Blog

The landscape of in situ hybridization (ISH), specifically fluorescence in situ hybridization (FISH), has undergone a transformative shift with the introduction of Nucleic Acid Mimics (NAMs). These modified probes, encompassing Peptide Nucleic Acid (PNA), Lock

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

The landscape of in situ hybridization (ISH), specifically fluorescence in situ hybridization (FISH), has undergone a transformative shift with the introduction of Nucleic Acid Mimics (NAMs). These modified probes, encompassing Peptide Nucleic Acid (PNA), Locked Nucleic Acid (LNA), 2′-O-Methyl-RNA, UNA (unlocked nucleic acid), and Phosphorodiamidate Morpholino Oligomers (PMOs), have emerged as groundbreaking tools, overcoming the limitations associated with traditional DNA and RNA probes.

Peptide Nucleic Acids (PNAs):

Peptide Nucleic Acids (PNAs) stand at the forefront of this molecular revolution, offering a fusion of DNA specificity and peptide versatility. The distinctive PNA backbone, composed of peptide linkages, ensures unparalleled stability and resistance to enzymatic degradation. With superior hybridization properties, PNAs bind to complementary DNA or RNA sequences with exceptional affinity, making them indispensable for applications ranging from targeted gene therapy to diagnostic assays and antisense technologies.

Unlocking the Potential: PNA’s Key Features:

Stability and Resistance:PNAs, characterized by a neutral polyamide backbone, showcase remarkable stability against nucleases and enzymatic degradation. This attribute enhances the half-life of PNA molecules, ensuring their efficacy in diverse experimental conditions.

High-Affinity Binding:The hybridization capabilities of PNAs are unparalleled, facilitating strong, sequence-specific binding to target nucleic acids. PNA’s shorter length allows for enhanced cell penetration and consistent hybridization performance, even under low salt concentrations. Its unique melting temperature response to single nucleotide changes enables precise probe design.

Versatility in Applications:PNAs find applications across a spectrum of research areas, including molecular diagnostics, gene editing, and nanotechnology. Their adaptability for specific sequences and functions makes PNAs an invaluable asset in the molecular biologist’s toolkit.

Locked Nucleic Acid (LNA):

Described in 1997, Locked Nucleic Acid (LNA) boasts a ribose ring locked in a specific conformation, ensuring water solubility and low toxicity. LNA’s design flexibility, including modifications like phosphorothioate, enhances resistance to nucleases without compromising affinity. Combining LNA with 2′-O-Methyl-RNA provides flexibility in melting temperature adjustments for optimized hybridization efficiency.

UNA and Other NAMs:

UNA, an acyclic RNA analog, offers flexibility, though it may impact nucleic acid duplex stability. Modifications like 2′-pyrene and 3′-O-amino-UNA address stability concerns, presenting potential applications in FISH experiments. Additionally, Phosphorodiamidate Morpholino Oligomers (PMOs), characterized by non-ionic properties and resistance to nucleases, have shown success in bacterial and fungal infection detection via FISH.

Challenges and Progress:

Despite the exceptional qualities of NAMs, particularly PNA and LNA, their widespread adoption in FISH for microorganism detection has been slower than anticipated. Challenges include hydrophobicity and water solubility issues for PNA probes, along with a general lack of awareness among laboratories. Nevertheless, studies showcasing PNA’s superior performance over traditional DNA probes underscore the promising potential of NAMs in microbial detection.

Conclusion:

As research in the field progresses, ongoing efforts are addressing the limitations associated with NAMs. Their unique features position them as compelling alternatives for FISH-based microorganism detection, holding the promise of unlocking new frontiers in advanced genetic research.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Clinical Trials and Research

Several clinical trials have explored the use of PADRE in cancer vaccines. For instance, vaccines targeting Mucin 1 (MUC1), a glycoprotein overexpressed in many cancers, have shown promising results when combined with PADRE. These vaccines have demonstrated the ability to elicit strong immune responses, including the production of antibodies against cancer-specific antigens.

Source: lifetein.com ↗

In Vivo Studies and Therapeutic Development

For peptides intended for animal studies or clinical use, TFA poses safety and efficacy risks. Its toxicity profile includes organ toxicity and immunogenicity, potentially invalidating preclinical data. Regulatory guidelines for Active Pharmaceutical Ingredients (APIs) require TFA levels <0.1%, necessitating rigorous removal protocols like LifeTein’s TFA Salt Exchange.

Source: lifetein.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to solubilize my synthetic peptides? #

Please refer to this FAQ for details: Handling and Storage of Synthetic Peptides. If the peptides are still cloudy, or turbid, you may have reached the limit of solubility. When the peptides are insoluble in the buffer, please try to sonicate, centrifuge, and lyophilize the peptide. Make sure to break the lyophilized lumps into a fine powder. Then try a small volume of a good agent 8M Urea, NMP, DMF, or DMSO to dissolve the peptide. Then dilute with water or your desired buffer. For peptides with Arg or LYs, you should try to lower the pH to 6 because the protonated amino acids will help solubility. Sonication and the following solvents may help with difficult peptides: 1) Begin with 100 % acetonitrile then dilute with water until 50% 2) Begin with 100% DMSO then dilute with water until 30 % 3) Dissolve it with 8M Urea 4) Dissolve it with 6 or 8 M Guanidine hydrochloride 5) 6M GuHCL, 0.05% TFA, pH2, 6) 100% TFA 7) 40% AcOH, 30%ACN, 30% water

Source: lifetein.com ↗
Storage reference

Enhanced Stability and Targeted Delivery

One of the primary advantages of incorporating peptides into LNPs is the enhanced stability of the nanoparticles. Peptides can protect the lipid components from degradation, ensuring that the therapeutic payload reaches its target site intact. Additionally, peptides can be designed to target specific cells or tissues, improving the efficacy and specificity of the delivery system.

Source: lifetein.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →